BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12707542)

  • 21. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 4-chloro-2,6-bis-(2-hydroxyl-benzyl)-phenol on healing of skin wounds and growth of bacteria.
    Oryan A; Khalafi-Nezhad A; Toloo N; Soltani Rad MN
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):585-91. PubMed ID: 18045344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of different topical agents on pseudomonas infection of burn wound].
    Guo Z; Gao W; He L
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Nov; 11(6):421-4. PubMed ID: 8728928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental study on the antibacterial effects of zirconium phosphate gauze loaded with silver on the common bacteria on rat burn wound].
    Tang J; Wu J; Yi SX; Wang RP; Wang XH; Ma B; Yuan J; Chen XW
    Zhonghua Shao Shang Za Zhi; 2004 Dec; 20(6):333-5. PubMed ID: 15730677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial properties of an iron-based hemostatic agent in vitro and in a rat wound model.
    Bracho DO; Barsan L; Arekapudi SR; Thompson JA; Hen J; Stern SA; Younger JG
    Acad Emerg Med; 2009 Jul; 16(7):656-60. PubMed ID: 19538502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pexiganan-incorporated collagen matrices for infected wound-healing processes in rat.
    Gopinath D; Kumar MS; Selvaraj D; Jayakumar R
    J Biomed Mater Res A; 2005 Jun; 73(3):320-31. PubMed ID: 15800884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds.
    Shanmugasundaram N; Uma TS; Ramyaa Lakshmi TS; Babu M
    J Biomed Mater Res A; 2009 May; 89(2):472-82. PubMed ID: 18431769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the prophylactic uses of topical mupirocin and nitrofurazone in murine crush contaminated wounds.
    Erdur B; Ersoy G; Yilmaz O; Ozkutuk A; Sis B; Karcioglu O; Parlak I; Ayrik C; Aksay E; Guryay M
    Am J Emerg Med; 2008 Feb; 26(2):137-43. PubMed ID: 18272091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
    Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
    Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
    [No Abstract]   [Full Text] [Related]  

  • 35. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y; Fan Y; Wang R; An MM; Liang BB
    J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel titanium wound chamber for the study of wound infections in pigs.
    Steinstraesser L; Vranckx JJ; Mohammadi-Tabrisi A; Jacobsen F; Mittler D; Lehnhardt M; Langer S; Kuhnen C; Gatermann S; Steinau HU; Eriksson E
    Comp Med; 2006 Aug; 56(4):279-85. PubMed ID: 16941955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties.
    Martineau L; Shek PN
    Burns; 2006 Mar; 32(2):172-9. PubMed ID: 16455202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds.
    Teo EY; Ong SY; Chong MS; Zhang Z; Lu J; Moochhala S; Ho B; Teoh SH
    Biomaterials; 2011 Jan; 32(1):279-87. PubMed ID: 20870283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression.
    Bielecki P; Glik J; Kawecki M; Martins dos Santos VA
    Biotechnol Lett; 2008 May; 30(5):777-90. PubMed ID: 18158583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.